J 2019

Oral Microbiota Composition and Antimicrobial Antibody Response in Patients with Recurrent Aphthous Stomatitis

STEHLIKOVA, Zuzana, Vojtech TLASKAL, Natalie GALANOVA, Radka ROUBALOVA, Jakub KREISINGER et. al.

Basic information

Original name

Oral Microbiota Composition and Antimicrobial Antibody Response in Patients with Recurrent Aphthous Stomatitis

Authors

STEHLIKOVA, Zuzana (203 Czech Republic), Vojtech TLASKAL (203 Czech Republic), Natalie GALANOVA (203 Czech Republic), Radka ROUBALOVA (203 Czech Republic), Jakub KREISINGER (203 Czech Republic), Jiri DVORAK (203 Czech Republic), Petra PROCHAZKOVA (203 Czech Republic), Klara KOSTOVCIKOVA (203 Czech Republic), Jirina BARTOVA (203 Czech Republic), Marketa LIBANSKA (203 Czech Republic), Radka CERMAKOVA (203 Czech Republic), Dagmar SCHIEROVA (203 Czech Republic), Antonín FASSMANN (203 Czech Republic, belonging to the institution), Petra BOŘILOVÁ LINHARTOVÁ (203 Czech Republic, belonging to the institution), Stepan COUFAL (203 Czech Republic), Miloslav KVERKA (203 Czech Republic), Lydie IZAKOVIČOVÁ HOLLÁ (203 Czech Republic, belonging to the institution), Jitka PETANOVA (203 Czech Republic), Helena TLASKALOVA-HOGENOVA (203 Czech Republic) and Zuzana JIRASKOVA ZAKOSTELSKA (203 Czech Republic, guarantor)

Edition

Microorganisms, Basel, MDPI, 2019, 2076-2607

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30208 Dentistry, oral surgery and medicine

Country of publisher

Switzerland

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

Impact factor

Impact factor: 4.152

RIV identification code

RIV/00216224:14110/19:00108595

Organization unit

Faculty of Medicine

UT WoS

000506646400054

Keywords in English

microbiome; mycobiome; oral mucosa

Tags

Tags

International impact, Reviewed
Změněno: 17/2/2020 14:45, Mgr. Tereza Miškechová

Abstract

V originále

Recurrent aphthous stomatitis (RAS) is the most common disease of the oral mucosa, and it has been recently associated with bacterial and fungal dysbiosis. To study this link further, we investigated microbial shifts during RAS manifestation at an ulcer site, in its surroundings, and at an unaffected site, compared with healed mucosa in RAS patients and healthy controls. We sampled microbes from five distinct sites in the oral cavity. The one site with the most pronounced differences in microbial alpha and beta diversity between RAS patients and healthy controls was the lower labial mucosa. Detailed analysis of this particular oral site revealed strict association of the genus Selenomonas with healed mucosa of RAS patients, whereas the class Clostridia and genera Lachnoanaerobaculum, Cardiobacterium, Leptotrichia, and Fusobacterium were associated with the presence of an active ulcer. Furthermore, active ulcers were dominated by Malassezia, which were negatively correlated with Streptococcus and Haemophilus and positively correlated with Porphyromonas species. In addition, RAS patients showed increased serum levels of IgG against Mogibacterium timidum compared with healthy controls. Our study demonstrates that the composition of bacteria and fungi colonizing healthy oral mucosa is changed in active RAS ulcers, and that this alteration persists to some extent even after the ulcer is healed.

Links

NV15-29336A, research and development project
Name: Změny imunologické reaktivity u pacientů s recidivujícími aftami